Stockreport

Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.

Oppenheimer Holdings, Inc. Class A (DE)  (OPY) 
US:NYSE Investor Relations: opco.com/investor-relations/index.aspx
PDF The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areasNEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. I [Read more]